723|367|Public
5|$|An {{example of}} a {{medicinal}} enzyme inhibitor is sildenafil (Viagra), a common treatment for male erectile dysfunction. This compound is a potent inhibitor of cGMP specific phosphodiesterase type 5, the enzyme that degrades the signalling molecule <b>cyclic</b> <b>guanosine</b> <b>monophosphate.</b> This signalling molecule triggers smooth muscle relaxation and allows blood flow into the corpus cavernosum, which causes an erection. Since the drug decreases {{the activity of the}} enzyme that halts the signal, it makes this signal last {{for a longer period of}} time.|$|E
25|$|The NO {{produced}} by {{this process is}} a potent activator of guanylyl cyclase (GC) by heme-dependent mechanisms; this activation results in formation of <b>cyclic</b> <b>guanosine</b> <b>monophosphate</b> (cGMP) from guanosine triphosphate (GTP). Among other roles, cGMP serves as a substrate for a cGMP-dependent protein kinase that activates myosin light chain phosphatase. Thus, production of NO from exogenous sources such as GTN increases the level of cGMP within the cell, and stimultates dephosphorylation of myosin.|$|E
25|$|Sildenafil protects <b>cyclic</b> <b>guanosine</b> <b>monophosphate</b> (cGMP) from {{degradation}} by cGMP-specific phosphodiesterase type 5 (PDE5) in {{the corpus}} cavernosum. Nitric oxide (NO) in the corpus cavernosum of the penis binds to guanylate cyclase receptors, {{which results in}} increased levels of cGMP, leading to smooth muscle relaxation (vasodilation) of the intimal cushions of the helicine arteries. This smooth muscle relaxation leads to vasodilation and increased inflow of blood into the spongy tissue of the penis, causing an erection. Robert F. Furchgott, Ferid Murad, and Louis Ignarro won the Nobel Prize in Physiology or Medicine in 1998 for their independent study of the metabolic pathway of nitric oxide in smooth muscle vasodilation.|$|E
5000|$|... #Article: <b>Cyclic</b> <b>guanosine</b> monophosphate-adenosine <b>monophosphate</b> ...|$|R
50|$|Degradation of <b>cyclic</b> di-GMP to <b>guanosine</b> <b>monophosphate</b> (GMP) is catalyzed by a {{phosphodiesterase}} (PDE).|$|R
50|$|Cyclic GMP-AMP synthase (cGAS), which {{belongs to}} the {{nucleotidyltransferase}} family, is able to recognize cytosolic DNA contents and induce STING-dependent interferon response by producing secondary messenger <b>cyclic</b> <b>guanosine</b> monophosphate-adenosine <b>monophosphate</b> (<b>cyclic</b> GMP-AMP, or cGAMP). After cyclic GMP-AMP bound STING is activated, it enhances TBK1's activity to phosphorylate IRF3 and STAT6 for downstream type I interferon response.|$|R
25|$|The binding of {{melatonin}} to melatonin receptors activates a few signaling pathways. MT1 receptor activation inhibits the adenylyl cyclase and its inhibition {{causes a}} rippling effect of non activation; starting with decreasing formation of {{cyclic adenosine monophosphate}} (cAMP), and then progressing to less protein kinase A (PKA) activity, which in turn hinders the phosphorylation of cAMP responsive element-binding protein (CREB binding protein) into P-CREB. MT1 receptors also activate phospholipase C (PLC), affect ion channels and regulate ion flux inside the cell. The binding of melatonin to MT2 receptors inhibits adenylyl cyclase which decreases the formation of cAMP. As well it hinders guanylyl cyclase and therefore the forming of <b>cyclic</b> <b>guanosine</b> <b>monophosphate</b> (cGMP). Binding to MT2 receptors probably affects PLC which increases protein kinase C (PKC) activity. Activation of the receptor can lead to ion flux inside the cell.|$|E
25|$|While some {{mutations}} in CNGA3 result in truncated and, presumably, non-functional channels this is largely not the case. While few mutations have received in-depth study, see table 1, {{at least one}} mutation does result in functional channels. Curiously, this mutation, T369S, produces profound alterations when expressed without CNGB3. One such alteration is decreased affinity for <b>Cyclic</b> <b>guanosine</b> <b>monophosphate.</b> Others include {{the introduction of a}} sub-conductance, altered single-channel gating kinetics, and increased calcium permeability. When mutant T369S channels coassemble with CNGB3, however, the only remaining aberration is increased calcium permeability. While it is not immediately clear how this increase in Ca2+ leads to ACHM, one hypothesis is that this increased current decreases the signal-to-noise ratio. Other characterized mutations, such as Y181C and the other S1 region mutations, result in decreased current density due to an inability of the channel to traffic to the surface. Such loss of function will undoubtedly negate the cone cell's ability to respond to visual input and produce achromatopsia. At least one other missense mutation outside of the S1 region, T224R, also leads to loss of function.|$|E
25|$|Ammonia {{toxicity}} {{is often}} seen through two routes of administration, either through consumption or through endogenous ailments such as liver failure. One notable case in which ammonia toxicity is common {{is in response to}} cirrhosis of the liver which results in hepatic encephalopathy, and can result in cerebral edema (Haussinger 2006). This cerebral edema can be the result of nervous cell remodeling. As a consequence of increased concentrations, ammonia activity in-vivo has been shown to induce swelling of astrocytes in the brain through increased production of cGMP (<b>Cyclic</b> <b>Guanosine</b> <b>Monophosphate)</b> within the cells which leads to Protein Kinase G-mediated(PKG) cytoskeletal modifications. The resultant effect of this toxicity can be reduced brain energy metabolism and function. Importantly, the toxic effects of ammonia on astrocyte remodling can be reduced through administration of L-carnitine. This astrocyte remodeling appears to be mediated through ammonia-induced mitochondrial permeability transition. This mitochondrial transition {{is a direct result of}} glutamine activity a compound which forms from ammonia in-vivo. Administration of antioxidants or glutaminase inhibitor can reduce this mitochondrial transition, and potentially also astrocyte remodeling.|$|E
5000|$|<b>Cyclic</b> <b>guanosine</b> monophosphate-adenosine <b>monophosphate</b> (<b>cyclic</b> GMP-AMP, cGAMP) is {{the first}} cyclic di-nucleotide found in metazoa. [...] In {{mammalian}} cells, cGAMP is synthesized by cyclic GMP-AMP synthase (cGAS) from ATP and GTP upon cytosolic DNA stimulation. cGAMP produced by cGAS contains mixed phosphodiester linkages, with one between 2'-OH of GMP and 5'-phosphate of AMP and the other between 3'-OH of AMP and 5'-phosphate of GMP.|$|R
50|$|Depolarization of rod cells (causing {{release of}} their neurotransmitter) occurs {{because in the}} dark, cells have a {{relatively}} high concentration of <b>cyclic</b> <b>guanosine</b> 3'-5' <b>monophosphate</b> (cGMP), which opens ion channels (largely sodium channels, though calcium can enter through these channels as well). The positive charges of the ions that enter the cell down its electrochemical gradient change the cell's membrane potential, cause depolarization, and lead {{to the release of}} the neurotransmitter glutamate. Glutamate can depolarize some neurons and hyperpolarize others, allowing photoreceptors to interact in an antagonistic manner.|$|R
50|$|Activation of {{rods and}} cones is {{actually}} hyperpolarization; {{when they are}} not being stimulated, they depolarize and release glutamate continuously. In the dark, cells have a relatively high concentration of <b>cyclic</b> <b>guanosine</b> 3'-5' <b>monophosphate</b> (cGMP), which opens ion channels (largely sodium channels, though calcium can enter through these channels as well). The positive charges of the ions that enter the cell down its electrochemical gradient change the cell's membrane potential, cause depolarization, and lead to the release of the neurotransmitter glutamate. Glutamate can depolarize some neurons and hyperpolarize others.|$|R
2500|$|A cyclic {{nucleotide}} (cNMP) is a single-phosphate nucleotide with a cyclic bond arrangement {{between the}} sugar and phosphate groups. [...] Like other nucleotides, cyclic nucleotides are composed of three functional groups: a sugar, a nitrogenous base, and a single phosphate group. [...] As {{can be seen in}} the cyclic adenosine monophosphate (cAMP) and <b>cyclic</b> <b>guanosine</b> <b>monophosphate</b> (cGMP) images, the 'cyclic' portion consists of two bonds between the phosphate group and the 3' and 5' hydroxyl groups of the sugar, very often a ribose.|$|E
2500|$|... eNOS has a {{protective}} {{function in the}} cardiovascular system, which is attributed to NO production. Regulation of the vascular tone {{is one of the}} best known roles of NO in the cardiovascular system. Once produced in endothelial cells, NO diffuses across the vascular smooth muscle cell membranes and activates the enzyme soluble guanylate cyclase (sGC), which catalyzes the conversion of guanosine triphosphate into <b>cyclic</b> <b>guanosine</b> <b>monophosphate</b> (cGMP). cGMP, in turn, activates protein kinase G (PKG), which promotes multiple phosphorylation of cellular targets lowering cellular Ca2+ concentrations and promoting vascular relaxation.|$|E
2500|$|Evgeny Fesenko, Stanislav Kolesnikov, and Arkady Lyubarsky {{discovered}} in 1985 that <b>cyclic</b> <b>guanosine</b> <b>monophosphate</b> (cGMP) can initiate the photoresponse in rods. Soon after, {{the role of}} cNMP in gated ion channels of chemosensitive cilia of olfactory sensory neurons was reported by Tadashi Nakamura and Geoffrey Gold. In 1992 Lawrence Haynes and King-Wai Yau uncovered cNMP’s role in the light-dependent cyclic-nucleotide-gated channel of cone photoreceptors. By {{the end of the}} decade, the presence of two types of intramembrane receptors was understood: Rs (which stimulates cyclase) and Ri (which inhibits cyclase). [...] Wei-Jen Tang and James Hurley reported in 1998 that adenylyl cyclase, which synthesizes cAMP, is regulated not only by hormones and neurotransmitters, but also by phosphorylation, calcium, forskolin, and guanine nucleotide-binding proteins (G proteins).|$|E
30|$|Several other HU-mediated {{mechanisms}} of disease amelioration {{have been reported}} including production of nitric oxide, regulation of soluble guanylyl cyclase, <b>cyclic</b> adenosine and <b>guanosine</b> <b>monophosphate</b> [36, 37] as well as erythropoietic stress response [38]. Furthermore, various signalling pathways have been implicated in HU-mediated fetal hemoglobin (HbF) induction such as the Giα/JNK/Jun [39]; p 38 /MAPK/CREB 1 [40]; cAMP-mediated response [41, 42]; erythropoietin (EPO)-induced activation of the ERK- 1 /ERK- 2 MAPK [43]; histone deacetylase (HDAC) and DNA methyl-transferase (DNMT) inhibitor-mediated epigenetic modification of γ-globin expression. Despite this, a complete understanding of HU-mediated HbF production remains incomplete.|$|R
40|$|AbstractLow-density lipoproteins {{activate}} isolated human platelets. The {{mechanism of}} this activation is unknown, but may involve increased phosphoinositide turnover. We {{have examined the}} effect of low-density lipoproteins on intracellular calcium concentrations in platelets loaded with the photoprotein aequorin. The lipoproteins induced concentration-dependent increases in intracellular calcium, associated with shape change and aggregation. These responses could be partially inhibited by the removal of extracellular calcium and by pre-incubation with acetylsalicylic acid. They were also antagonised by agents which increase cellular concentrations of <b>cyclic</b> adenosine and <b>guanosine</b> <b>monophosphates.</b> It {{is not clear whether}} the platelet-lipoprotein interaction involves a ‘classical’ lipoprotein receptor...|$|R
30|$|The host takes use {{of pattern}} {{recognition}} receptors (PRRs) {{to defend against}} pathogen invasion or cellular damage. Among microorganism-associated molecular patterns detected by host PRRs, nucleic acids derived from bacteria or viruses are tightly supervised, providing a fundamental mechanism of host defense. Pathogenic DNAs {{are supposed to be}} detected by DNA sensors that induce the activation of NFκB or TBK 1 -IRF 3 pathway. DNA sensor cGAS is widely expressed in innate immune cells and is a key sensor of invading DNAs in several cell types. cGAS binds to DNA, followed by a conformational change that allows the synthesis of <b>cyclic</b> <b>guanosine</b> monophosphate–adenosine <b>monophosphate</b> (cGAMP) from adenosine triphosphate and guanosine triphosphate. cGAMP is a strong activator of STING that can activate IRF 3 and subsequent type I interferon production. Here we describe recent progresses in DNA sensors especially cGAS in the innate immune responses against pathogenic DNAs.|$|R
5000|$|... #Caption: <b>Cyclic</b> <b>guanosine</b> <b>mono{{phosphate}}.</b> The cyclic portion {{refers to}} the two single bonds between the phosphate group and the ribose ...|$|E
5000|$|... 8-Bromoguanosine 3',5'-cyclic monophosphate is a {{brominated}} {{derivative of}} <b>cyclic</b> <b>guanosine</b> <b>monophosphate</b> (cGMP). [...] It {{acts as an}} activator of cGMP-dependent protein kinases.|$|E
5000|$|... cAMP is {{degraded}} by phosphodiesterases (PDE). The PDE5 inhibitors sildenafil and vardenafil, the cAMP-promoter IBMX and 8-CPT-cGMP (a <b>cyclic</b> <b>guanosine</b> <b>monophosphate</b> (cGMP) analogue) increase melanin synthesis.|$|E
40|$|SummaryActivation of the DNA-dependent cytosolic {{surveillance}} pathway {{in response}} to Mycobacterium tuberculosis infection stimulates ubiquitin-dependent autophagy and inflammatory cytokine production, and {{plays an important role}} in host defense against M.  tuberculosis. However, the identity of the host sensor for M.  tuberculosis DNA is unknown. Here we show that M.  tuberculosis activated <b>cyclic</b> <b>guanosine</b> monophosphate-adenosine <b>monophosphate</b> (cGAMP) synthase (cGAS) in macrophages to produce cGAMP, a second messenger that activates the adaptor protein stimulator of interferon genes (STING) to induce type I interferons and other cytokines. cGAS localized with M.  tuberculosis in mouse and human cells and in human tuberculosis lesions. Knockdown or knockout of cGAS in human or mouse macrophages blocked cytokine production and induction of autophagy. Mice deficient in cGAS were more susceptible to lethality caused by infection with M.  tuberculosis. These results demonstrate that cGAS is a vital innate immune sensor of M.  tuberculosis infection...|$|R
40|$|International audienceA twice-as-smart ligand {{is a small}} {{molecule}} that {{experiences a}} structural switch upon interaction with its target (i. e., smart ligand) that concomitantly triggers its fluorescence (i. e., smart probe). Prototypes of twice-as-smart ligands were recently developed to track and label G-quadruplexes: these higher-order nucleic acid structures originate in the assembly of four guanine(G) -rich DNA or RNA strands, whose stability is imparted by the formation and the self-assembly of G-quartets. The first prototypes of twice-as-smart quadruplex ligands were designed to exploit the self-association of quartets, being themselves synthetic G-quartets. While their quadruplex recognition capability has been thoroughly documented, some doubts remain about the precise photophysical mechanism that underlies their peculiar spectroscopic properties. Here, we uncovered this mechanism via complete theoretical calculations. Collected information was then used to develop a novel application of twice-as-smart ligands, as efficient chemical sensors of bacterial signaling pathways via the fluorescent detection of naturally occurring extracellular quadruplexes formed by <b>cyclic</b> dimeric <b>guanosine</b> <b>monophosphate</b> (c-di-GMP) ...|$|R
40|$|PA 4608 is {{a single}} PilZ domain protein from Pseudomonas aeruginosa that binds to <b>cyclic</b> dimeric <b>guanosine</b> <b>monophosphate</b> (c-di-GMP). Although the monomeric {{structure}} of unbound PA 4608 has been studied in detail, the molecular details of c-di-GMP binding to this protein are still uncharacterized. Hence, we determined the solution structure of c-di-GMP bound PA 4608. We found that PA 4608 undergoes conformational changes to expose the c-di-GMP binding site by ejection of the C-terminal 310 helix. A dislocation of the C-terminal tail {{in the presence of}} c-di-GMP implies that this region acts as a lid that alternately covers and exposes the hydrophobic surface of the binding site. In addition, mutagenesis and NOE data for PA 4608 revealed that conserved residues are in contact with the c-di-GMP molecule. The unique structural characteristics of PA 4608, including its monomeric state and its ligand binding characteristics, yield insight into its function as a c-di-GMP receptor...|$|R
50|$|This type of PRA has {{an early}} onset of severe vision loss. It {{is caused by}} a defect in the gene for cGMP-phosphodiesterase, which leads to retinal levels of <b>cyclic</b> <b>guanosine</b> <b>monophosphate</b> ten times normal.|$|E
50|$|A {{phosphodiesterase}} inhibitor is a {{drug that}} blocks {{one or more of}} the five subtypes of the enzyme phosphodiesterase (PDE), thereby preventing the inactivation of the intracellular second messengers cyclic adenosine monophosphate (cAMP) and <b>cyclic</b> <b>guanosine</b> <b>monophosphate</b> (cGMP) by the respective PDE subtype(s).|$|E
50|$|Nesiritide (Natrecor) is the {{recombinant}} {{form of the}} 32 {{amino acid}} human B-type natriuretic peptide, which is normally produced by the ventricular myocardium. Nesiritide works to facilitate cardiovascular fluid homeostasis through counterregulation of the renin-angiotensin-aldosterone system, stimulating <b>cyclic</b> <b>guanosine</b> <b>monophosphate,</b> leading to smooth muscle cell relaxation.|$|E
40|$|The Burkholderia cepacia complex (Bcc) {{consists}} of 17 {{closely related species}} that are problematic opportunistic bacterial pathogens for cystic fibrosis patients and immunocompromised individuals. These bacteria are capable of utilizing two different chemical languages: N-acyl homoserine lactones (AHLs) and cis- 2 -unsaturated fatty acids. Here we summarize the current knowledge of the underlying molecular architectures of these communication systems, showing how they are interlinked and discussing how they regulate overlapping as well as specific sets of genes. A particular focus is laid {{on the role of}} these signaling systems in the formation of biofilms, which are believed to be highly important for chronic infections. We review genes that have been implicated in the sessile lifestyle of this group of bacteria. The new emerging role of the intracellular second messenger <b>cyclic</b> dimeric <b>guanosine</b> <b>monophosphate</b> (c-di-GMP) as a downstream regulator of the fatty acid signaling cascade and as a key factor in biofilm formation is also discussed...|$|R
40|$|Background: Recent {{studies have}} {{revealed}} that the properties Traditional Chinese Medicine is mostly associated with are substance and energy metabolism. Our study aimed to compare the effect of red ginseng (RG) (warm property) and ginseng leaves (GL; cold property) on the substance and energy metabolism of rats with hypothyroidism. Materials and methods: Rats were administered propylthiouracil intraperitoneally for 20 d to cause hypothyroidism. The reference group was orally administered Aconiti Lateralis Radix Praeparaia [FZ (Fuzi in Chinese) ], while both the RG and GL groups were orally administrated crude drugs. The rectal, tail, toe, and axilla temperature of the rats were assayed every 3 d. Oxygen consumption, carbon dioxide production, heat production, and energy expenditure were measured via TSE phenoMaster/LabMaster animal monitoring system. Adenosine monophosphate-activated protein kinase, Na+-K+-ATPase, fumarase, pyruvic acid and <b>cyclic</b> adenosine monophosphate/cyclic <b>guanosine</b> <b>monophosphate</b> were determined. Results: The lower levels of triiodothyronine, tetraiodothyronine, and thyrotropin-releasing hormone and the higher level of thyroid stimulating hormone revealed the successful establishment of a hypothyroidism model. Oxygen consumption, carbon dioxide production, heat production, and energy expenditure in the FZ and RG groups were obviously increased. The activity of Na+-K+-ATPase and fumarase in the FZ and RG groups was significantly increased. The <b>cyclic</b> adenosine monophosphate/cyclic <b>guanosine</b> <b>monophosphate</b> level in the FZ and RG groups was increased, while the GL group showed the opposite. Conclusion: Our research provides {{a new way to}} explore the efficiency of Chinese medicine {{on the basis of the}} relationship between drug property and effects on substance and energy metabolism...|$|R
40|$|Dendritic cell (DC) {{activation}} and {{antigen presentation}} {{are critical for}} efficient priming of T cell responses. Here, we study how lentiviral vectors (LVs) deliver antigen and activate DCs to generate T cell immunization in vivo. We report that antigenic proteins delivered in vector particles via pseudotransduction were sufficient to stimulate an antigen-specific immune response. The delivery of the viral genome encoding the antigen increased {{the magnitude of this}} response in vivo but was irrelevant in vitro. Activation of DCs by LVs was independent of MyD 88, TRIF, and MAVS, ruling out an involvement of Toll-like receptor or RIG-I–like receptor signaling. Cellular DNA packaged in LV preparations induced DC activation by the host STING (stimulator of interferon genes) and cGAS (<b>cyclic</b> <b>guanosine</b> monophosphate–adenosine <b>monophosphate</b> synthase) pathway. Envelope-mediated viral fusion also activated DCs in a phosphoinositide 3 -kinase–dependent but STING-independent process. Pseudotransduction, transduction, viral fusion, and delivery of cellular DNA collaborate to make the DC-targeted LV preparation an effective immunogen...|$|R
50|$|<b>Cyclic</b> <b>guanosine</b> <b>monophosphate</b> (cGMP) is a cyclic {{nucleotide}} {{derived from}} guanosine triphosphate (GTP). cGMP {{acts as a}} second messenger much like cyclic AMP. Its most likely mechanism of action is activation of intracellular protein kinases {{in response to the}} binding of membrane-impermeable peptide hormones to the external cell surface.|$|E
50|$|Part of the {{physiological}} process of erection involves {{the release of}} nitric oxide (NO) in vasculature of the corpus cavernosum {{as a result of}} sexual stimulation. NO activates the enzyme guanylate cyclase which results in increased levels of <b>cyclic</b> <b>guanosine</b> <b>monophosphate</b> (cGMP), leading to smooth muscle relaxation in blood vessels supplying the corpus cavernosum, resulting in increased blood flow and an erection.|$|E
50|$|TAS1R1 and TAS1R2 receptors {{have been}} shown to bind to G proteins, most often the gustducin Gα subunit, {{although}} a gustducin knock-out has shown small residual activity. TAS1R1 and TAS1R2 have also been shown to activate Gαo and Gαi. This suggests that TAS1R1 and TAS1R2 are G protein-coupled receptors that inhibit adenylyl cyclases to decrease <b>cyclic</b> <b>guanosine</b> <b>monophosphate</b> (cGMP) levels in taste receptors.|$|E
40|$|AbstractVasodilator-stimulated phosphoprotein (VASP), an actin binding protein {{localized}} {{to areas}} of focal contacts, is a substrate for the <b>cyclic</b> adenosine monophosphate/cyclic <b>guanosine</b> <b>monophosphate</b> (cAMP/cGMP) -dependent protein kinases (PKA, PKG). In this study, {{we show that}} serum stimulation of vascular smooth muscle cells (SMCs) induces VASP phosphorylation on Ser 157, in a mechanism not dependent on PKA or PKG. We tested the possibility that protein kinase C (PKC), a regulator of cytoskeletal function, is involved. PKC inhibition or down-regulation prevented serum-induced phosphorylation of VASP at Ser 157 in rat vascular SMCs. Additionally, recombinant PKCα directly phosphorylated Ser 157 on VASP. In summary, our data {{support the hypothesis that}} PKC phosphorylates VASP and mediates serum-induced VASP regulation...|$|R
40|$|Many {{bacterial}} pathogens produce diffusible signal factor (DSF) -type quorum sensing (QS) {{signals in}} modulation of virulence and biofilm formation. Previous work on Xanthomonas campestris {{showed that the}} RpfC/RpfG two-component system is involved in sensing and responding to DSF signals, but little is known in other microorganisms. Here we show that in Burkholderia cenocepacia the DSF-family signal cis- 2 -dodecenoic acid (BDSF) negatively controls the intracellular <b>cyclic</b> dimeric <b>guanosine</b> <b>monophosphate</b> (c-di-GMP) level through a receptor protein RpfR, which contains Per/Arnt/Sim (PAS) -GGDEF-EAL domains. RpfR regulates the same phenotypes as BDSF including swarming motility, biofilm formation, and virulence. In addition, the BDSF(-) mutant phenotypes could be rescued by in trans expression of RpfR, or its EAL domain that functions as a c-di-GMP phosphodiesterase. BDSF is shown to bind to the PAS domain of RpfR with high affinity and stimulates its phosphodiesterase activity through induction of allosteric conformational changes. Our work presents a unique and widely conserved DSF-family signal receptor that directly links the signal perception to c-di-GMP turnover in regulation of bacterial physiology...|$|R
40|$|The {{presence}} of DNA in the cytoplasm of mammalian cells {{is a danger}} signal that triggers host immune responses such as the production of type I interferons. Cytosolic DNA induces interferons through the production of <b>cyclic</b> <b>guanosine</b> monophosphate–adenosine <b>monophosphate</b> (<b>cyclic</b> GMP-AMP, or cGAMP), which binds to and activates the adaptor protein STING. Through biochemical fractionation and quantitative mass spectrometry, we identified a cGAMP synthase (cGAS), which belongs to the nucleotidyltransferase family. Overexpression of cGAS activated the transcription factor IRF 3 and induced interferon-b in a STING-dependent manner. Knockdown of cGAS inhibited IRF 3 activation and interferon-b induction by DNA transfection or DNA virus infection. cGAS bound to DNA in the cytoplasm and catalyzed cGAMP synthesis. These results indicate that cGAS is a cytosolic DNA sensor that induces interferons by producing the second messenger cGAMP. DNA was known to stimulate immuneresponses long before it was shown to bea genetic material, but the mechanism by which DNA functions as an immune stim-ulant remains poorly understood (1). Although DNA can stimulate the production of type I in-terferons in dendritic cells through binding t...|$|R
